The Division of Corporation Finance from time to time posts announcements to address topics of interest to public companies and others who follow developments related to the SEC’s full and fair disclosure program. This page contains a cumulative listing of all such announcements published since 2011. You may sign up to receive these announcements by email as they become available.

Date
Title
Date: Title: Notification of Completion of Exchange Act Filing Reviews
Date: Title: SEC Staff to Release Filing Review Correspondence Earlier
Date: Title: Division announcement regarding confidential submission of draft registration statements under the Jumpstart Our Business Startups Act
Date: Title: Republication of Commission Orders Revoking Exchange Act Registration and Stop Orders Under the Securities Act on EDGAR
Date: Title: Division update regarding submission of draft registration statements for confidential review under the JOBS Act and non-public review under the Division’s policy for certain foreign private issuers
Date: Title: Division update regarding the submission of draft registration statements submitted under the Jumpstart Our Business Startups Act and Division policy for certain foreign private issuers
Date: Title: Draft Registration Statements to Be Submitted and Filed on EDGAR
Date: Title: Draft Registration Statements Required to Be Submitted and Filed Using EDGAR Beginning October 15, 2012
Date: Title: Notice required by the Iran Threat Reduction and Syria Human Rights Act of 2012 to be filed through EDGAR
Date: Title: Acceleration of registration statements if there is a change in the SEC's operating status
Date: Title: "Glossy" annual reports to security holders submitted to the SEC in paper will no longer be viewable on the SEC’s web site
Date: Title: Division announces change to procedures relating to granted applications for confidential treatment
Date: Title: Draft Filing Review Program for Asset-Backed Securities Issuers
Announcement for Draft Filing Review Program for Asset-Backed Securities Issuers
Date: Title: Division of Corporation Finance Will Express No Views under Exchange Act Rule 14a-8(i)(9) for Current Proxy Season
Date: Title: SEC Staff to Release Correspondence Relating to Securities Act Registration Statements That Are Not Reviewed
Announcement relating to the release of no-review letters on EDGAR
Date: Title: Recently Enacted Transportation Law Includes a Number of Changes to the Federal Securities Laws


Date: Title: Opportunity for Companies to Test File in Preparation for Crowdfunding Offerings
Date: Title: Opportunity for Issuers to Receive Feedback on Test Filings in Preparation for Asset-Backed Securities Offerings That Require Asset-Level Data
Date: Title: "Tandy" Representations No Longer Needed in Filing Reviews
Date: Title: Draft Registration Statement Processing Procedures Expanded
Date: Title: False Telephone Communications Claiming to Be from the SEC
Date: Title: Division to Release through EDGAR Serious Deficiencies Letters
Date: Title: Division of Corporation Finance Staff to Continue to Enhance Transparency of Staff Actions
Date: Title: New Rules and Procedures for Exhibits Containing Immaterial, Competitively Harmful Information
Date: Title: Announcement Regarding Rule 14a-8 No-Action Requests
Date: Title: Disclosure Program Realignment
Date: Title: CF Disclosure Guidance Topic: Intellectual Property and Technology Risks Associated with International Business Operations
Date: Title: CF Disclosure Guidance Topic: Confidential Treatment Applications Submitted Pursuant to Rules 406 and 24b-2
Date: Title: Division of Corporation Finance Operating Status
Date: Title: Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns
Date: Title: CF Disclosure Guidance Topic: Coronavirus (COVID-19)
Date: Title: Staff Guidance for Conducting Shareholder Meetings in Light of COVID-19 Concerns
Date: Title: Division of Corporation Finance Statement Regarding Requirements for Form 144 Paper Filings in Light of COVID-19 Concerns
Date: Title: Division of Corporation Finance Statement Regarding Requirements for Certain Paper Documents (other than Forms 144) in Light of COVID-19 Concerns
Date: Title: CF Disclosure Guidance Topic: COVID-19 Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources
Date: Title: Division of Corporation Finance Statement Regarding Requirements for Certain Paper Documents (other than Forms 144) in Light of COVID-19 Concerns
Date: Title: Division of Corporation Finance Statement Regarding Requirements for Form 144 Paper Filings in Light of COVID-19 Concerns
Date: Title: Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns
Date: Title: Division of Corporation Finance Statement Regarding Submission of Supplemental Materials and Information Subject to Rule 83 Confidential Treatment Requests in Light of COVID-19 Concerns
Date: Title: CF Disclosure Guidance Topic No. 7 updated to provide new guidance relating to options available to companies whose confidential treatment orders are about to expire.
Date: Title: Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns
Date: Title: CF Disclosure Guidance Topic: Disclosure Considerations for China-Based Issuers
Date: Title: CF Disclosure Guidance Topic: Special Purpose Acquisition Companies
  • Show
  • Items
1 to 43 of 43 items